Talk:Bausch Health

This article is rated B-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Canada: Quebec Low‑importance

	Canada portal This article is within the scope of WikiProject Canada, a collaborative effort to improve the coverage of Canada on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CanadaWikipedia:WikiProject CanadaTemplate:WikiProject CanadaCanada-related articles
Low	This article has been rated as Low-importance on the project's importance scale.
	This article is supported by WikiProject Quebec.

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

This article is written in Canadian English, which has its own spelling conventions (colour, centre, travelled, realize, analyze) and some terms that are used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus.

This is the talk page for discussing improvements to the Bausch Health article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Why?[edit]

WHY no one wright something about Milan panic`s ICN, Valeants forebear ICN Pharmaceuticals, ICN was very important company in pharmaceuticals word?

Dead link?[edit]

http://www.forbes.com/feeds/ap/2008/10/09/ap5530646.html <-- regarding this link, how do we even know that the story was there, about this topic? What if I made a link like this: http://www.forbes.com/feeds/ap/2008/10/09/za3339990646.html same result. So what's the point? TheSoundAndTheFury (talk) 15:19, 28 May 2013 (UTC)[reply]

Controversy, Congressional hearings[edit]

Nothing in the article about the Senate hearings, which caused a significant drop in Valeant's share price, and Valeant's pricing strategy.

^[1]

Valeant caught the eye of Congress this year after it increased the price of two heart medications it had just bought the rights to sell: Nitropress and Isuprel. Valeant raised the price of Nitropress 212 percent and Isuprel 525 percent.

While other multinational pharmaceutical companies spend well into the double digits as a percentage of sales, Valeant’s 2014 annual report shows that the company spent $246 million on research and development — just 3 percent of sales. Another way to think about that: Valeant paid its five highest-paid executives 1.5 percent of sales, or $123 million, last year.

The Senate report details layoffs made by Valeant after three large acquisitions: Medicis Pharmaceutical in 2012, Bausch & Lomb in 2013 and Salix Pharmaceuticals this year.

When Medicis was acquired, it had 790 full-time employees, the report said. Valeant terminated 750 of them, mostly in the United States.

Bausch & Lomb had 4,103 workers when Valeant came calling. It fired 3,000 workers in that acquisition, half domestically.

--Nbauman (talk) 19:05, 3 October 2015 (UTC)[reply]

Done XyZAn (talk) 16:10, 5 October 2015 (UTC)[reply]

Updating market numbers[edit]

Valeant was listed as a Canadian stock to watch in September, 2015.^[2]

"Now coming to Canadian stocks, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) surged 2.38% in the last trading session to close at $228.22. The Net Income (ttm) of the company is $831.00 million.The company generates revenue of $9.26 billion. Its 52-Week low range is $111.41 and 52-week high range is $263.81. Its price to earnings (P/E) ratio stands at 93.82. The price range of the company is from $222.03 to $229.07 with the earning per share (EPS) is $2.43. The company traded at the volume of 1.47 million whereas, its Average trading volume (over the course of 30 days) is 1.88 million. The market capitalization of the company is $75.99 billion and the Investor held shares are 341.19 million."

Products[edit]

This was removed from content by editor user:XyZAn removed "until formatted more appropriately."

Lodosyn, a treatment for Parkinson's disease costs $1,860.28 for a thirty day supply or $5,339.04 for ninety days.^[3]

References[edit]

^ Morgenson, Gretchen (2 October 2015). "Valeant's High-Price Drug Strategy". Retrieved 2 October 2015.
^ Smith, Adam (16 September 2015 \accessdate=5 October 2015), Canadian Stocks to Watch: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Toronto-Dominion Bank (NYSE:TD), Canadian National Railway (USA) (NYSE:CNI) {{citation}}: Check date values in: |date= (help)
^ "Medicare D". Medicare. 2014. Retrieved 12 November 2015.

External links modified[edit]

Hello fellow Wikipedians,

I have just modified one external link on Valeant Pharmaceuticals. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:

Added archive https://web.archive.org/web/20141011165706/http://www.biospace.com/news_story.aspx?NewsEntityId=105546 to http://www.biospace.com/news_story.aspx?NewsEntityId=105546

When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.

This message was posted before February 2018. After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than regular verification using the archive tool instructions below. Editors have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the RfC before doing mass systematic removals. This message is updated dynamically through the template {{source check}} (last update: 18 January 2022).

If you have discovered URLs which were erroneously considered dead by the bot, you can report them with this tool.
If you found an error with any archives or the URLs themselves, you can fix them with this tool.

Cheers.—InternetArchiveBot (Report bug) 07:08, 7 January 2018 (UTC)[reply]

Acquisitions removal[edit]

That behemoth is a thing to behold, although all the info is likely duplicated in the company's History subsections. Is it entirely up to date with all acquisitions? Also, I'd like to look into a way of making it smaller if kept, if not removing it outright due to it's sheer size. 30Four (talk) 07:24, 10 May 2023 (UTC)[reply]

Ativan is killing people[edit]

Withdrawal from the drug Ativan is known to be highly addictive and withdrawal or a sudden reduce in dosage carries a warning of potential death, seizures, hear failure, suicide, tortuous anxiety, etc. etc. It is the number one drug prescribed in North America. 2607:FEA8:2DE0:5D40:64A7:3910:F81B:91B0 (talk) 21:11, 25 June 2023 (UTC)[reply]

[NYT_2_Oct_2015-1] Morgenson, Gretchen (2 October 2015). "Valeant's High-Price Drug Strategy". Retrieved 2 October 2015.

[newsoracle-2] Smith, Adam (16 September 2015 \accessdate=5 October 2015), Canadian Stocks to Watch: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Toronto-Dominion Bank (NYSE:TD), Canadian National Railway (USA) (NYSE:CNI) {{citation}}: Check date values in: |date= (help)

[Medicare-3] "Medicare D". Medicare. 2014. Retrieved 12 November 2015.

[1]

[2]

[3]